249 related articles for article (PubMed ID: 35841781)
21. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
22. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
[TBL] [Abstract][Full Text] [Related]
23. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
Yuan S; Chan JFW; Chik KKH; Chan CCY; Tsang JOL; Liang R; Cao J; Tang K; Chen LL; Wen K; Cai JP; Ye ZW; Lu G; Chu H; Jin DY; Yuen KY
Pharmacol Res; 2020 Sep; 159():104960. PubMed ID: 32473310
[TBL] [Abstract][Full Text] [Related]
24. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives.
Zhu Q; Xu Y; Wang T; Xie F
Front Immunol; 2022; 13():1053437. PubMed ID: 36505489
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.
Ketenci S; Uygar Kalaycı M; Dündar B; Duranay R; Şükrü Aynacıoğlu A
Int Immunopharmacol; 2022 Sep; 110():108939. PubMed ID: 35717836
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
27. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
Corley MJ; Pang APS; Dody K; Mudd PA; Patterson BK; Seethamraju H; Bram Y; Peluso MJ; Torres L; Iyer NS; Premeaux TA; Yeung ST; Chandar V; Borczuk A; Schwartz RE; Henrich TJ; Deeks SG; Sacha JB; Ndhlovu LC
J Leukoc Biol; 2021 Jul; 110(1):21-26. PubMed ID: 33464637
[TBL] [Abstract][Full Text] [Related]
29. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
Dhankhar P; Dalal V; Kumar V
J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
[TBL] [Abstract][Full Text] [Related]
30. Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia.
Tao Z; Zhang L; Friedemann T; Yang G; Li J; Wen Y; Wang J; Shen A
J Funct Foods; 2020 Dec; 75():104243. PubMed ID: 33072190
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Zhang C; Zhou C; Shi L; Liu G
Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
[TBL] [Abstract][Full Text] [Related]
32. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
[TBL] [Abstract][Full Text] [Related]
33. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
34. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
35. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
Front Immunol; 2022; 13():995235. PubMed ID: 36172368
[TBL] [Abstract][Full Text] [Related]
36. GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.
Foo CX; Bartlett S; Chew KY; Ngo MD; Bielefeldt-Ohmann H; Arachchige BJ; Matthews B; Reed S; Wang R; Smith C; Sweet MJ; Burr L; Bisht K; Shatunova S; Sinclair JE; Parry R; Yang Y; Lévesque JP; Khromykh A; Rosenkilde MM; Short KR; Ronacher K
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36396144
[TBL] [Abstract][Full Text] [Related]
37. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
Guo J; Wei X; Li Q; Li L; Yang Z; Shi Y; Qin Y; Zhang X; Wang X; Zhi X; Meng D
J Cell Physiol; 2020 Dec; 235(12):9884-9894. PubMed ID: 32510598
[TBL] [Abstract][Full Text] [Related]
39. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
40. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.
Zhang H; Ai JW; Yang W; Zhou X; He F; Xie S; Zeng W; Li Y; Yu Y; Gou X; Li Y; Wang X; Su H; Zhu Z; Xu T; Zhang W
Clin Infect Dis; 2021 Aug; 73(3):376-385. PubMed ID: 32463434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
